首页> 外国专利> ORAL FORMULATIONS MIMETIC OF ROUX-EN-Y GASTRIC BYPASS ACTIONS ON THE ILEAL BRAKE; COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS AND SYSTEMS FOR TREATMENT OF METABOLIC SYNDROME MANIFESTATIONS INCLUDING INSULIN RESISTANCE, FATTY LIVER DISEASE, HYPERLIPIDEMIA, AND TYPE 2 DIABETES

ORAL FORMULATIONS MIMETIC OF ROUX-EN-Y GASTRIC BYPASS ACTIONS ON THE ILEAL BRAKE; COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS AND SYSTEMS FOR TREATMENT OF METABOLIC SYNDROME MANIFESTATIONS INCLUDING INSULIN RESISTANCE, FATTY LIVER DISEASE, HYPERLIPIDEMIA, AND TYPE 2 DIABETES

机译:ROUX-EN-Y胃肠道旁路动作对假制动的口头配方的含糊性;代谢综合征的组成,治疗方法,诊断方法和系统,包括胰岛素抵抗,脂肪肝疾病,高脂血症和2型糖尿病

摘要

The invention provides compositions, methods, and diagnostics for the treatment of metabolic syndromes. In an additional aspect of the invention, compositions and methods of treatment are calibrated to mimic the ileal brake response resulting from surgical intervention, e.g. RYGB, to control metabolic syndrome manifestations and thereby reverse or ameliorate the cardiovascular damage (atherosclerosis, hypertension, lipid accumulation, and the like) resulting from progression of metabolic syndrome. Combination medicaments that act synergistically on the ileal brake and the manifestations of metabolic syndrome are also disclosed.
机译:本发明提供了用于治疗代谢综合征的组合物,方法和诊断剂。在本发明的另一个方面,校准了组合物和治疗方法以模仿由外科手术例如手术引起的回肠制动反应。 RYGB,以控制代谢综合征的表现,从而逆转或减轻由代谢综合征的进展引起的心血管损害(动脉粥样硬化,高血压,脂质蓄积等)。还公开了对回肠制动和代谢综合征的表现具有协同作用的组合药物。

著录项

  • 公开/公告号US2019262367A1

    专利类型

  • 公开/公告日2019-08-29

    原文格式PDF

  • 申请/专利权人 VOLANT HOLDINGS GMBH;

    申请/专利号US201816059199

  • 发明设计人 JOSEPH M. FAYAD;JEROME SCHENTAG;

    申请日2018-08-09

  • 分类号A61K31/7004;A61K45/06;A61K31/195;A61K31/20;A61K31/40;A61K36/8998;A61K9;A61K9/28;A61K31/155;A61K9/48;A61K31/4985;A61K31/555;A61K36/05;A61K36/48;

  • 国家 US

  • 入库时间 2022-08-21 12:08:05

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号